Griffith University’s Institute for Glycomics has received a Federal Government grant to partner with China to create a world-first drug to treat children infected with Hand, Foot and Mouth Disease (HFMD) across Asia-Pacific.
General Manager of the Institute for Glycomics Dr Chris Davis was among the 38 researchers and commercialisation professionals across Australia who would each receive $7000 in Priming Grants.
Dr Chris Davis.
Local MP for Moncrieff Steven Ciobo met with Dr Davis at the Gold Coast campus in recognition of the funding announcement.
Dr Davis said the Priming Grant was essential to building people-to-people links and developing their product.
“Networking is essential in China and this grant enables me to travel to Chengdu and create relationships with businesses who will be able to commercialise the project,” Dr Davis said.
“HFMD is a widespread virus across the Asia-Pacific region, causing death and an economic burden, so there is high demand for a drug which will

See Full Post >>